The study, published in the Annals of Internal Medicine, examined antibiotic prescribing pratices within the Department of Veterans Affairs.
Antibiotic overuse is a common observation across the healthcare spectrum and a new study published in the Annals of Internal Medicine examines prescribing pratices within the Department of Veterans Affairs (VA). The retrospective cross-sectional study that included VA systems across the nation as well as the CDC evaluated antibiotic prescription trends over an 8-year period (2005 to 2012) in all emergency departments and primary and urgent care clinics in the VA health system.
The patients whose electronic health records were examined all had a primary diagnosis of acute respiratory infection (ARI) with typically low proportions of bacterial infection. Patients with infections or comorbid conditions that indicated antibiotic use were excluded. The authors measured overall antibiotic prescription; macrolide prescription; and patient, provider, and setting characteristics.
The study found that 10% of healthcare providers write an antibiotic prescription for nearly every patient (95% or more) with a cold, bronchitis, or other ARI. Importantly, the study pointed to variation in provider prescribing practices having a biger influence on variation in antibiotic prescription, more than patient characteristics, standards of practice at different hospitals, or clinical settings.
Read more here.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More